108 related articles for article (PubMed ID: 21924841)
1. Prostate cancer with Paneth cell-like neuroendocrine differentiation and extensive perineural invasion: coincidence or causal relationship?
Kakies C; Hakenberg OW; Gunia S; Erbersdobler A
Pathol Res Pract; 2011 Nov; 207(11):715-7. PubMed ID: 21924841
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer Ki-67 (MIB-1) expression, perineural invasion, and gleason score as biopsy-based predictors of prostate cancer mortality: the Mayo model.
Tollefson MK; Karnes RJ; Kwon ED; Lohse CM; Rangel LJ; Mynderse LA; Cheville JC; Sebo TJ
Mayo Clin Proc; 2014 Mar; 89(3):308-18. PubMed ID: 24486077
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of paneth cell-like neuroendocrine differentiation in adenocarcinoma of the prostate.
Tamas EF; Epstein JI
Am J Surg Pathol; 2006 Aug; 30(8):980-5. PubMed ID: 16861969
[TBL] [Abstract][Full Text] [Related]
4. Perineural invasion as a predictor of biochemical outcome following radical prostatectomy for select men with clinically localized prostate cancer.
D'Amico AV; Wu Y; Chen MH; Nash M; Renshaw AA; Richie JP
J Urol; 2001 Jan; 165(1):126-9. PubMed ID: 11125380
[TBL] [Abstract][Full Text] [Related]
5. A case of prostatic adenocarcinoma with Paneth cell-like appearance.
Nakamura Y; Fujishima F; Watanabe M; Taniuchi S; Ishida K; Ishidoya S; Arai Y; Sasano H
Pol J Pathol; 2011; 62(1):60-4. PubMed ID: 21574107
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic role of perineural invasion in prostate biopsy].
GutiƩrrez C; Terrasa F; Briones G; Conde G; Fuentes I; Hidalgo F; Bestard J; Rebassa M
Actas Urol Esp; 2011 Jun; 35(6):347-53. PubMed ID: 21435742
[TBL] [Abstract][Full Text] [Related]
7. Lymphovascular invasion is an independent prognostic factor in prostatic adenocarcinoma.
Cheng L; Jones TD; Lin H; Eble JN; Zeng G; Carr MD; Koch MO
J Urol; 2005 Dec; 174(6):2181-5. PubMed ID: 16280760
[TBL] [Abstract][Full Text] [Related]
8. Frequency and number of neuroendocrine tumor cells in prostate cancer: no difference between radical prostatectomy specimens from patients with and without neoadjuvant hormonal therapy.
Shimizu S; Kumagai J; Eishi Y; Uehara T; Kawakami S; Takizawa T; Koike M
Prostate; 2007 May; 67(6):645-52. PubMed ID: 17342745
[TBL] [Abstract][Full Text] [Related]
9. Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer.
Masieri L; Lanciotti M; Nesi G; Lanzi F; Tosi N; Minervini A; Lapini A; Carini M; Serni S
Urol Int; 2010; 85(4):396-400. PubMed ID: 20516669
[TBL] [Abstract][Full Text] [Related]
10. Can perineural invasion on prostate needle biopsy predict prostate specific antigen recurrence after radical prostatectomy?
de la Taille A; Rubin MA; Bagiella E; Olsson CA; Buttyan R; Burchardt T; Knight C; O'Toole KM; Katz AE
J Urol; 1999 Jul; 162(1):103-6. PubMed ID: 10379750
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative factors in localized prostate carcinoma treated with radical prostatectomy: importance of percentage of biopsies that contain tumor and the presence of biopsy perineural invasion.
Quinn DI; Henshall SM; Brenner PC; Kooner R; Golovsky D; O'Neill GF; Turner JJ; Delprado W; Grygiel JJ; Sutherland RL; Stricker PD
Cancer; 2003 Apr; 97(8):1884-93. PubMed ID: 12673714
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis.
Ellis CL; Partin AW; Han M; Epstein JI
J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of the diameter of perineural invasion in radical prostatectomy specimens.
Maru N; Ohori M; Kattan MW; Scardino PT; Wheeler TM
Hum Pathol; 2001 Aug; 32(8):828-33. PubMed ID: 11521227
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of proliferation activity and neuroendocrine differentiation to predict treatment failure after radical prostatectomy.
May M; Siegsmund M; Hammermann F; Loy V; Gunia S
Scand J Urol Nephrol; 2007; 41(5):375-81. PubMed ID: 17853019
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of epithelial and mesenchymal proteins in a panel of prostate cancer cell lines.
Murali AK; Norris JS
J Urol; 2012 Aug; 188(2):632-8. PubMed ID: 22704442
[TBL] [Abstract][Full Text] [Related]
16. Neuroendocrine cells in the prostatic carcinomas after neoadjuvant hormonal therapy.
Chen X; Okada H; Gotoh A; Arakawa S; Kamidono S
Kobe J Med Sci; 1997 Apr; 43(2):71-81. PubMed ID: 9385786
[TBL] [Abstract][Full Text] [Related]
17. Perineural invasion on prostate biopsy does not predict adverse pathological outcome.
Elharram M; Margel D; Finelli A; Trachtenberg J; Evans A; van der Kwast TH; Sweet JM; Fleshner N
Can J Urol; 2012 Dec; 19(6):6567-72. PubMed ID: 23228294
[TBL] [Abstract][Full Text] [Related]
18. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
[TBL] [Abstract][Full Text] [Related]
19. Difficulties in interpreting specimens after neoadjuvant hormonal therapy and radiation with illustration of neuroendocrine differentiation.
Civantos F
Mol Urol; 2000; 4(3):117-21; discussion 123. PubMed ID: 11062365
[TBL] [Abstract][Full Text] [Related]
20. Perineural invasion of prostate carcinoma cells is associated with reduced apoptotic index.
Yang G; Wheeler TM; Kattan MW; Scardino PT; Thompson TC
Cancer; 1996 Sep; 78(6):1267-71. PubMed ID: 8826950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]